Australia markets closed

BELLUS Health Inc. (BLU)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
10.59-0.28 (-2.62%)
As of 09:46AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 981.71M
Enterprise value 748.59M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)50.19k
Price/book (mrq)3.55
Enterprise value/revenue 46.79k
Enterprise value/EBITDA -10.73

Trading information

Stock price history

Beta (5Y monthly) -0.49
52-week change 3268.47%
S&P500 52-week change 3-11.01%
52-week high 311.10
52-week low 32.60
50-day moving average 38.32
200-day moving average 37.09

Share statistics

Avg vol (3-month) 3917.41k
Avg vol (10-day) 31.27M
Shares outstanding 5106.75M
Implied shares outstanding 6N/A
Float 861.42M
% held by insiders 111.27%
% held by institutions 188.92%
Shares short (14 June 2022) 412.75M
Short ratio (14 June 2022) 418.76
Short % of float (14 June 2022) 4N/A
Short % of shares outstanding (14 June 2022) 411.94%
Shares short (prior month 12 May 2022) 411.98M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 318 Aug 2019
Ex-dividend date 4N/A
Last split factor 2277:1000
Last split date 318 Aug 2019

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-454,187.50%

Management effectiveness

Return on assets (ttm)-20.90%
Return on equity (ttm)-33.82%

Income statement

Revenue (ttm)16k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)0.00%
Gross profit (ttm)16k
EBITDA N/A
Net income avi to common (ttm)-69.83M
Diluted EPS (ttm)-0.81
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)233.97M
Total cash per share (mrq)2.19
Total debt (mrq)845k
Total debt/equity (mrq)0.30
Current ratio (mrq)15.33
Book value per share (mrq)2.62

Cash flow statement

Operating cash flow (ttm)-60.13M
Levered free cash flow (ttm)-31.8M